Aimmune Expects ‘Robust’ Demand For Peanut Allergy Treatment Palforzia, Though Slow Launch

The COVID-19 Pandemic Is Expected To Affect The Launch

 
• By Brenda Sandburg
  
Aimmune Palforzia Capsule
Aimmune launches Palforzia, the first FDA-approved peanut allergy treatment
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip